SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001178913-08-002558
Filing Date
2008-09-29
Accepted
2008-09-29 10:23:45
Documents
13
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 zk85861.htm 10-K 1044796
2 GRAPHIC ernst.jpg GRAPHIC 6903
3 GRAPHIC pluristem.jpg GRAPHIC 3583
4 exhibit_3-1.htm EX-3.1 49553
5 GRAPHIC img001.jpg GRAPHIC 4386
6 GRAPHIC img002.jpg GRAPHIC 1905
7 GRAPHIC img003.jpg GRAPHIC 1620
8 exhibit_21-1.htm EX-21.1 1679
9 exhibit_23-1.htm EX-23.1 2544
10 exhibit_31-1.htm EX-31.1 7886
11 exhibit_31-2.htm EX-31.2 7888
12 exhibit_32-1.htm EX-32.1 3451
13 exhibit_32-2.htm EX-32.2 3446
  Complete submission text file 0001178913-08-002558.txt   1148945
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905 972-4-850-1080
PLURISTEM THERAPEUTICS INC (Filer) CIK: 0001158780 (see all company filings)

IRS No.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-31392 | Film No.: 081092720
SIC: 2836 Biological Products, (No Diagnostic Substances)